Varian wins FDA clearance for Nexus DR digital X-ray

Varian Medical (NYSE:VAR) said yesterday that it won 510(k) clearance from the FDA for its Nexus DR digital X-ray system.

The Palo Alto-based company markets the device as a single common imaging platform intended for general radiographic procedures, but not for fluoroscopy, angiography, or mammography.

The announcement comes a week after Varian acquired Polish distributor Candela for an undisclosed amount.

The Nexus DR system is made of 4 primary components: An image detector, a high-resolution monitor, a computer and Varian’s image processing software. It complies with the provisions of the European Medical Device Directive and it will soon be CE Marked, according to the company.

“Nexus DR enables an operator to acquire, display, process, transmit, export images to portable media and send images over a network for long term storage,” Carl LaCasce, the VP of sales & marketing for Varian’s Imaging Components group, said in prepared remarks. “The advanced image processing algorithms in the Nexus DR make it possible to bring out diagnostic details that can be difficult to see using conventional imaging techniques.”

Varian’s shares were trading at $96.15 apiece in mid-afternoon activity yesterday, up 1.69%.

The post Varian wins FDA clearance for Nexus DR digital X-ray appeared first on MassDevice.

from MassDevice http://ift.tt/2cTWDq4